Encephalitozoonosis in pharmacologically immunosuppressed mice

Area of Science:

• Immunology
• Parasitology
• Microbiology

Background:

• Encephalitozoon cuniculi causes opportunistic infections in immunocompromised individuals.
• Pharmacological immunosuppression increases susceptibility to parasitic infections.

Purpose of the Study:

• To evaluate Encephalitozoon cuniculi infection in mice treated with immunosuppressive drugs.
• To determine the role of specific immune cells in controlling E. cuniculi infection.

Main Methods:

• Mice were immunosuppressed using cyclophosphamide or cyclosporin.
• Mice were inoculated with E. cuniculi spores.
• Immune cell populations were analyzed using flow cytometry (FACS).
• E. cuniculi was identified using microscopy and PCR.

Main Results:

• Cyclophosphamide-induced immunosuppression led to fatal encephalitozoonosis with reduced CD8(+), CD4(+), CD3(+) T cells, and CD19(+) B cells.
• Cyclosporin treatment resulted in milder, chronic, non-lethal infections with reduced CD3(+) and CD4(+) T cells.
• CD8(+) T cells play a significant role in controlling E. cuniculi infection.

Conclusions:

• CD8(+) T cells are critical for controlling Encephalitozoon cuniculi.
• Immunosuppressive therapies, like chemotherapy, necessitate preventive strategies against E. cuniculi zoonosis.